No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 3.2x · 10Y median 0.6x · 100th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 13
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T18:09:19.806Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T18:09:19.806Z. Latest historical point 2024-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T18:09:19.806Z. Latest historical point 2024-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T18:09:19.806Z. Latest historical point 2024-09-30.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T18:09:19.806Z. Latest historical point 2024-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T18:09:19.806Z. Latest historical point 2024-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Quanome Technologies, Inc. (QNME) stock was $0.54 as of Oct 6, 2026, 2:04 PM EDT, down 7.18% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -55.3%
Following a name change from Lakeside Holding Limited in August 2026, the company shifted its strategic focus to technologies, applications, and partnerships at the intersection of quantum computing, artificial intelligence, and advanced simulation. The company's initial areas of interest include quantum and AI-enabled decision systems, molecular and materials simulation, and pharmaceutical and healthcare applications.
Airlines, Airports & Air Services · Itasca, IL
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-0.18
vs Estimate
N/A
Revenue
$-8589574.00
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1QNME | $18.52M | $0.54 | -7.18% | -55.26% | N/A | N/A | N/A |
| 2TRSG | $18.66M | $1.14 | +0.97% | -21.44% | N/A | N/A | vs QNME |
| 3RECT | $18.27M | $1.26 | +0.00% | -63.87% | N/A | N/A | vs QNME |
| 4CTRM | $18.84M | $1.95 | -1.02% | -7.91% | -26.69% | N/A | vs QNME |
| 5ARTW | $17.06M | $3.28 | -0.61% | +17.76% | -2.52% | +1.58% | vs QNME |
| 6TLIH | $16.91M | $5.75 | -0.17% | +3.39% | N/A | N/A | vs QNME |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$0.54
High
N/A
